We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVXL icon
2151
Anavex Life Sciences
AVXL
$231M
$409K ﹤0.01%
47,700
+12,704
+36% +$127K
FRXB.WS
2152
CALL
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$408K ﹤0.01%
41,035
RBOT
2153
DELISTED
Vicarious Surgical
RBOT
$407K ﹤0.01%
+5,979
New +$465K
CCC
2154
CCC Intelligent Solutions
CCC
$3.55B
$406K ﹤0.01%
+45,300
New +$403K
APMIW
2155
CALL
DELISTED
AxonPrime Infrastructure Acquisition Corporation Warrants
APMIW
$406K ﹤0.01%
39,015
JGGCW
2156
CALL
DELISTED
Jaguar Global Growth Corporation I Warrant
JGGCW
$403K ﹤0.01%
38,793
-86,205
-69% -$6.87K
LII icon
2157
Lennox International
LII
$15B
$402K ﹤0.01%
+1,600
New +$404K
VERI icon
2158
Veritone
VERI
$92.9M
$400K ﹤0.01%
68,613
-4,145
-6% -$28.5K
MATW icon
2159
Matthews International
MATW
$887M
$399K ﹤0.01%
+11,055
New +$407K
WLDN icon
2160
Willdan Group
WLDN
$1.02B
$399K ﹤0.01%
+25,514
New +$458K
GTX icon
2161
Garrett Motion
GTX
$5.37B
$397K ﹤0.01%
+51,848
New +$401K
PRPH
2162
DELISTED
ProPhase Labs
PRPH
$397K ﹤0.01%
5,208
-3,705
-42% -$299K
RDFN
2163
DELISTED
Redfin
RDFN
$396K ﹤0.01%
43,741
+6,009
+16% +$44.8K
ICUI icon
2164
ICU Medical
ICUI
$4.16B
$396K ﹤0.01%
+2,401
New +$413K
ABR icon
2165
Arbor Realty Trust
ABR
$977M
$396K ﹤0.01%
34,422
-121,234
-78% -$1.68M
ABT icon
2166
Abbott
ABT
$187B
$395K ﹤0.01%
+3,905
New +$412K
OCEAW
2167
CALL
DELISTED
Ocean Biomediacal, Inc. Warrants
OCEAW
$394K ﹤0.01%
59,403
GTES icon
2168
Gates Industrial Corporation Ltd.
GTES
$6.31B
$394K ﹤0.01%
+28,367
New +$378K
QTWO icon
2169
Q2 Holdings
QTWO
$3.78B
$394K ﹤0.01%
+16,000
New +$476K
BWEN icon
2170
Broadwind
BWEN
$81.7M
$393K ﹤0.01%
+102,231
New +$435K
TUR icon
2171
CALL
iShares MSCI Turkey ETF
TUR
$201M
$391K ﹤0.01%
12,000
-10,800
-47% -$372K
EAF icon
2172
GrafTech
EAF
$184M
$391K ﹤0.01%
8,045
+5,695
+242% +$308K
MLCO icon
2173
Melco Resorts & Entertainment
MLCO
$2.21B
$391K ﹤0.01%
+30,703
New +$395K
PXE icon
2174
Invesco Energy Exploration & Production ETF
PXE
$87.5M
$390K ﹤0.01%
+14,460
New +$413K
WKHS icon
2175
Workhorse Group
WKHS
$33.4M
$387K ﹤0.01%
97
-175
-64% -$966K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.